Premium
Effect of chronic bradykinin B 2 receptor blockade on blood pressure of conscious Dahl salt‐resistant rats
Author(s) -
Mukai Hiroya,
Fitzgibbon Wayne R,
Ploth David W,
Margolius Harry S
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701797
Subject(s) - bradykinin , endocrinology , medicine , antagonist , blood pressure , chemistry , receptor , receptor antagonist
In this study 3 protocols were utilized to determine the role of endogenous kinins in the resistance of the inbred Dahl (Rapp) salt‐resistant (SR/Jr) rats to high salt diet‐induced blood pressure elevation. The bradykinin B 2 receptor antagonist, Hoe 140 ( D ‐Arg[Hyp 3 , Thi 5 , D ‐Tic 7 , Oic 8 ]‐bradykinin) at doses of either 10–20 or 20–40 nmol day −1 (subcutaneously (s.c), via osmotic minipumps, for either 1 or 3 weeks during a high (8%) salt diet) effectively blocked or attenuated the hypotensive responses to 100–1000 ng of bradykinin. In the first protocol, 5 week old SR/Jr rats treated with Hoe 140 (10–20 nmol day −1 , n =9, s.c., via osmotic minipumps) for 3 weeks and concomitantly fed high (8%) NaCl diet had significantly higher conscious tail cuff blood pressures (BPc) at 1 and 3 weeks when compared with rats treated with vehicle (0.9% NaCl, n =6). The differences in BPc between the 2 groups were 13 mmHg ( P <0.001) after 1 week and 8 mmHg ( P <0.05) after 3 weeks of treatment. In the second protocol, 5 week old SR/Jr rats were treated with Hoe 140 (20–40 nmol day −1 , n =8, s.c., via osmotic minipumps) or vehicle ( n =8) for 3 weeks. During the first week of treatment the rats were fed normal (0.8%) NaCl diet. The rats were then switched to 8% NaCl for 2 remaining weeks of the protocol. The mean BPc of Hoe 140‐treated rats was not significantly different from that of the vehicle‐treated rats when fed 0.8% NaCl diet. In contrast, rats treated with Hoe 140 and concomitantly fed high (8%) NaCl diet had significantly increased BPc (123±2 vs 111±1 mmHg, P <0.001 for the Hoe 140‐ and vehicle‐treated rats, respectively). In the third protocol, treatment with Hoe 140 (20–40 nmol day −1 , s.c., via osmotic minipumps) during high salt diet did not increase BPc in rats that were pre‐exposed to the high salt diet for 2 weeks. At the end of 3 weeks of study, blood pressure was measured via an arterial catheter during pentobarbitone‐induced anaesthesia. Rats treated with Hoe 140 for 1 or 3 weeks had significantly lower mean arterial blood pressures than the vehicle‐treated rats. Our findings suggest that in SR/Jr rats, kinin activation of bradykinin B 2 receptors at least partially contributes to early regulatory mechanisms that resist an increase in blood pressure following exposure to a high salt diet. The mechanism underlying the decreased blood pressure during pentobarbitone anaesthesia of SR/Jr rats chronically treated with Hoe 140 has yet to be elucidated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom